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The potential of microfluidic lung epithelial
wounding: towards in vivo-like alveolar
microinjuries†
M. Felder,ab A. O. Stucki,ab J. D. Stucki,ab T. Geisercd and O. T. Guenat*ace
Idiopathic pulmonary fibrosis (IPF) remains a major clinical challenge to date. Repeated alveolar epithelial
microinjuries are considered as the starting point and the key event in both the development and the
progression of IPF. Various pro-fibrotic agents have been identified and shown to cause alveolar damage.
In IPF, however, no leading cause of alveolar epithelial microinjuries can be identified and the exact
etiology remains elusive. New results from epidemiologic studies suggest a causal relation between IPF and
frequent episodes of gastric refluxes resulting in gastric microaspirations into the lung. The eﬀect of gastric
contents on the alveolar epithelium has not been investigated in detail. Here, we present a microfluidic
lung epithelial wounding system that allows for the selective exposure of alveolar epithelial cells to gastric
contents. The system is revealed to be robust and highly reproducible. The thereby created epithelial
microwounds are of tiny dimensions and best possibly reproduce alveolar damage in the lung. We further
demonstrate that exposure to gastric contents, namely hydrochloric acid (HCl) and pepsin, directly
damages the alveolar epithelium. Together, this novel in vitro wounding system allows for the creation of
in vivo-like alveolar microinjuries with the potential to study lung injury and alveolar wound repair in vitro.
Insight, innovation, integration
Current in vitro wounding systems are limited in reproducibility and often fail to mimic injuries of smallest dimensions, as observed in the epithelium of the
human alveolus. Here, we present a microfluidic wounding system that allows for the formation of tailor-made in vivo-like alveolar microinjuries. With the aid
of an aqueous two phase system, we demonstrate that exposure to gastric contents causes alveolar injuries with profound loss of epithelial barrier integrity, a
key event in the development of pulmonary fibrosis. Such wounding systems for injuries with dimensions relevant to the human alveolus may crucially
contribute to a better understanding of the pathomechanisms underlying chronic lung diseases.
Introduction
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and
fatal lung disease of unknown origin. Initially, IPF was thought
to be the consequence of chronic low-grade inflammation in the
lung parenchyma. However, during the past few decades anti-
inflammatory treatment strategies were revealed to be ineﬀective
in IPF patients. Furthermore, new results suggest that fibrosis
evolves even in the absence of inflammation. These findings
led to a clear distinction between fibrotic and inflammatory
processes,1 followed by a paradigm shift in the pathomechanism
underlying IPF. Consequently, a ‘‘deregulated alveolar repair’’
model replaced the prevailing hypothesis of ‘‘inflammation-
driven’’ IPF.2,3 Accordingly, pulmonary fibrosis is the consequence
of improper wound healing upon repeated injuries to the alveolar
epithelium. In a healthy lung, the alveolar epithelium regenerates
after injury by the action of type II alveolar epithelial cells. These
cells act as local progenitor cells of the alveolus and show
stem cell-like properties.4,5 In IPF, however, the self-regenerative
potential of the alveolus is overstrained and the injured epithelium
is replaced by non-functional restrictive scar tissue. Injuries to the
alveolar epithelium are typically of tiny dimensions ranging from
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single cell death to multicellular lesions, hereinafter referred to
as alveolar microinjuries. Numerous pro-fibrotic agents with
deleterious eﬀects on alveolar epithelial cells were identified.
Among those, microaspirations of gastric refluxates recently
emerged as potential key factors in the development of IPF.6,7
Indeed, epidemiologic studies revealed a significantly higher
prevalence of gastroesophageal reflux disease (GERD) among
IPF patients (66–94% vs. 10–20% in control population).8–10
Microaspirations are episodes of gastric reflux inhalations that
enter into the peripheral lung. Such refluxates can be gaseous,
liquid or a mixture of both with various acidic concentrations.11
The detection of pepsin, a digestive enzyme from the stomach,
in bronchoalveolar lavage (BAL) fluid has become an unequivocal
marker for microaspirations.12,13 Similar to other digestive enzymes,
pepsin is secreted as an inactive pro-enzyme and activated only upon
its proteolytic cleavage at the site of action. The activation of pepsin
is strongly pH-dependent and triggered by hydrochloric acid (HCl).
Peak activity of pepsin was reported at pH 1.5–2.5,14 which correlates
with normal HCl-levels in gastric juice. Peptic activity gradually
decreases with increasing pH-levels with complete inactivation at
neutral pH. In the pH-range of acidic microaspiration (pH o 4),
however, approximately 70% of the peptic peak activity persists.
Interestingly, Johnston and colleagues demonstrated that inactive
pepsin at neutral pH remains stable on laryngeal epithelium after a
simulated reflux event.15 Subsequent pH-drops, possibly induced by
successive acidic microaspirations, can then reactivate the silenced
pepsin and cause severe tissue damage. Similar studies report
pepsin-induced cell injuries in esophageal16 and bronchial cells.17
However, the effect of pepsin on peripheral lung epithelium and its
potential implications for the development of IPF remain unknown.
In this study, we present an in vitro microfluidic wounding
model that allows for the reproduction of in vivo-like alveolar
epithelial microinjuries. In the first step, epithelial wounds of
dimensions relevant to the human alveolus,18 are reproduced.
Therefore, a trypsin–EDTA based flow focusing technique
reported recently by our group and others for epithelial19 and
endothelial20 wound healing is pushed to its limit to inflict
microinjuries of smallest wound dimensions. In sharp contrast
to conventional scratch assays, this technique allows targeting
a very limited amount of cells and enables the formation of
micrometer-wide epithelial injuries. Such microinjuries are
thought to be the trigger and the cause of progression in IPF.
An adequate in vitro reproduction of the alveolar microinjuries
is therefore crucial for the investigation of IPF-related alveolar
wound healing. In addition, a multiple of those injuries are
created within the same epithelial layer to modulate multi-focal
lesions, typically found in IPF. In the second step, an in vivo-like
wounding agent is investigated. Although, trypsin-induced lung
injury has been demonstrated in a rat model of pancreatitis,21
its physiologic relevance in humans remains limited.22 Therefore,
instead of trypsin, two key compounds of gastric refluxates, pepsin
and hydrochloric acid (HCl), were used to induce microinjuries to
the alveolar epithelium. The presence of a strong acid in the flow
focusing system leads to an additional difficulty, the fast diffusion
of protons across the microfluidic system. To overcome this
limitation, an aqueous two-phase system is implemented to limit
the diffusion of protons and to allow the acidified pepsin solution to
remain active in the central flow. Aqueous two-phase systems have
recently been reported in the context of cell culture in a microfluidic
environment. Takayama and colleagues described a patterning
technique for selective cell and reagent deposition,23,24 whereas
Petrak et al. microprinted cells to create organized constructs for
tissue engineering applications.25 The aqueous two-phase technique
is used here for the first time to create flow focusedmicrowounds in
a confluent cell layer. The resulting microwounds unprecedentedly
recapitulate microaspiration-induced lung injuries.
Materials and methods
Microfluidic platform: design and fabrication
A system of converging microchannels was designed using
CAD-based construction software to enable hydrodynamic flow
focusing. The design (Fig. 1) consists of a 750 mm wide and
10 mm long rectangular microchannel that can individually be
accessed on each side by three separate inlets and outlets,
respectively. Inlets and outlets, hereinafter referred to as access
channels, are 210 mm wide and 4.5 mm long. The 100 mm high
microfluidic channel has a total volume of 0.75 ml, whereas the
access channels each have a volume of roughly 0.1 ml. An epoxy
mold, made of Accura Extreme, was fabricated by stereolithography
(Proform AG, Switzerland). Soft replicas of polydimethylsiloxane
(PDMS, Dow Corning) casts were manufactured according to
standard rapid prototyping protocols(24). Access ports were
punched using a 1.5 mm dermal biopsy punch (Shoney Scientific,
India). PDMS casts andmicroscope glass slides were then sonicated
for 5 min in 100% ethanol (EtOH), rinsed with purified water and
Fig. 1 Schematic drawing (a) and picture (b) of the microfluidic platform
filled with red dye. Six regularly arranged access channels converge into a
750 mm wide, 100 mm high and 10 mm long rectangular microchannel. Six
identical access ports (highlighted in light gray), mark the entry to the three
individual inlets or outlets, respectively. Nine unambiguous position markers
(highlighted in dark gray) are evenly distributed along the microchannel.
Scale bar: 2 mm.
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dried with compressed air. Exposure to O2-plasma for 25 s at
650 mTorr (Harrick Plasma, USA) enabled covalent bonding of
PDMS casts and glass slides. After bonding, the assembled
microfluidic platforms were post-baked overnight at 60 1C in
order to strengthen the sealing between the PDMS cast and the
glass substrate.26
Epithelial cell culture
Cell culture experiments were performed according to a protocol
described previously.19 In brief, all cell manipulations were
performed under a laminar flow cabinet according to aseptic
working techniques. Human type II alveolar epithelial-like A549
cells (ATCC, USA), passage numbers 20 to 40, were cultured in
RPMI 1640medium (Gibco) supplemented with 10% fetal bovine
serum (Gibco), 100 Uml1 penicillin and 100 mgml1 streptomycin
(Gibco), hereinafter referred to as complete culture medium.
Microfluidic platforms, prior to experimentation, were sterilized
using UV-exposure for 15 min and rigorous rinsing with 70%
ethanol (EtOH). Sterilized platforms were then wetted with
isopropanol, followed by serial dilutions of EtOH, sterile water
and complete culture medium. The four lateral access ports were
plugged with autoclaved and hermetically sealed polyether ether
ketone (PEEK) tubings of approximately 1.6 mm (1/1600) outer
diameter (VWR). Overnight incubation of complete culture medium
at 37 1C and 5% CO2 in the microfluidic platform enabled protein
adsorption to the PDMS cast27 and basic coating of the glass
substrate. High density cell suspension of 6  106 cells per ml was
then injected into the central inlet port resulting in a seeding density
of 6  103 cells per cm2. Excess medium was removed. Loaded
microfluidic platforms were then placed in humidity chambers and
incubated at 37 1C and 5% CO2. Once the epithelial cells firmly
adhered to the substrate, the central inlet port was connected to a
medium filled syringe (BD Biosciences, USA) using 1.6mmdiameter
Polytetrafluoroethylene (PTFE) tubings (Bohlender, Germany).
Medium filled syringe reservoirs were further loaded on respective
syringe pumps (Harvard Apparatus, USA). Under continuous
perfusion with 0.1 ml min1 complete culture medium, cells
were grown to confluence within two to three days. The displaced
medium was collected in 1.5 ml eppendorf tubes via PTFE tubings.
Upon confluence, the entire microchannel system was rinsed twice
with pre-warmed (37 1C) complete culture medium.
Trypsin–EDTA epithelial layer wounding
Hydrodynamic flow focusing was used to expose a confluent
layer of alveolar epithelial-like (A549) cells to tailored wounding
patterns as reported earlier.19 Briefly, a central flow carrying a
wounding agent, 0.5% trypsin–EDTA (Gibco), was maintained
in the middle part of the channel while complete culture
medium was perfused on both sides of the main flow stream.
These sheath flows protected the underlying epithelial layer.
Three independent parameters (the microwound width, the
time to create a microinjury in the cell layer and the micro-
wound localization) were investigated to fully explore and
evaluate the potential of microfluidic wound creation based
on flow focusing. The corresponding experimental set-ups are
described in detail below. Importantly, in order to provide
uniform culture conditions, all wounding experiments were
performed under a predefined level of shear stress by utilizing a
constant overall flow rate of 15 ml min1.
Microwound width. Complete culture medium and the
trypsin–EDTA solution were injected from two syringe pumps.
Prior to experimentation, the sheath flows were each injected at
7.5 ml min1 for 5 min. Trypsin–EDTA was then injected at a
flow rate of 0.5, 1, 2, 3 and ultimately 5 ml min1, while, at the
same time, the sheath flow was reduced accordingly to maintain
an overall flow rate of 15 ml min1. The ratio between the
wounding and the overall flow rate was thereby set at 1 : 30,
1 : 15, 1 : 7.5, 1 : 5 or 1 : 3, respectively. Between each consecutive
wounding episode, the wounding flow was transiently stopped
and the cells were washed for 3 min with complete culture
medium only. Bright-field micrographs were taken using the
JuLI Fluorescent Cell Analyzer (Witec, Switzerland) before and
after each wounding at 10 succeeding channel segments along
the entire microchannel. Using FIJI software (NIH, USA), the
wound width was then measured at 5 random positions within
every channel segment. Data derived from channel segments
with apparent flow disturbances, such as cell aggregates, dust
particles or air bubbles, were excluded from further analysis.
Similarly, segments in proximity to the channel openings were
excluded from analysis. Thereby, only data from undisturbed
and fully developed parabolic flow profiles were utilized. Data are
represented as means  standard deviations of four independent
experiments.
For visualization purposes, sodium-fluorescein (F6377,
Sigma) was dissolved in D-PBS (Gibco) to a final concentration
of 1 mg ml1 and injected together with the sheath flow of
D-PBS only into a microfluidic platform without cells. Bright-field
and fluorescence micrographs were taken at the corresponding
segments and overlaid using digital image processing software
(AxioVision, Zeiss). To determine the theoretical wound widths, a
simple computer simulation was run using the finite-element
analysis software COMSOL Multiphysics. The laminar flow simula-
tion is based on the Navier–Stokes equation with no slip boundary
conditions (velocity at the border is zero). Streamline projections
from the central inlet were plotted for the five indicated flow ratios
1 : 3–1 :30. The theoretical wound widths were then determined by
the resulting width of the streamline projections in the center of
the channel.
Time to create a microinjury in the epithelial layer. The
microfluidic platform was mounted on a stage top incubator of
a Zeiss LSM710 laser scanning microscope equipped with an
automated stage drive for live cell imaging at 37 1C and 5%
CO2. Both trypsin–EDTA and complete culture medium were
perfused via long PTFE-tubing arranged within the incubation
box to adjust for temperature variations. A centered flow of focused
trypsin–EDTA was then injected for selective cell exposure. Similar
to the aforementioned wound width analysis, five different
exposure patterns were tested: 1 : 30, 1 : 15, 1 : 7.5, 1 : 5 and 1 : 3.
A fully confluent cell layer was used for every exposure pattern.
Wound formation was monitored by a series of consecutive
micrographs recorded along the entire microchannel length.
This procedure was repeated every other minute during the
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whole experiment. Consecutive micrographs were then stitched
together using the MosaicJ plugin of the FIJI software. At each
time point, the length of the created wound was determined as
the distance between the channel opening and the position at
which the most distant cell detached.
Microwound localization. To precisely control the localization of
the focused flow of trypsin–EDTA within the microchannel, the
sheath flow was injected via two separate syringe pumps. In Fig. 5,
a representative example of this set of experiments is depicted.
Trypsin–EDTA was injected at 2 ml min1 into the central inlet.
Meanwhile, complete culture medium was perfused at a total of
13 ml min1 (ratio central-to-sheath flow 1 : 7.5) from the lateral
inlets. In contrast to the aforementioned experiments, complete
culture medium was injected at unequal flow rates from the
lateral inlets. In the first step, the sheath flow was injected at
3 ml min1 from the left and 10 ml min1 from the right inlet. The
focused flow of trypsin–EDTA was thus directed towards the left.
After formation of a first de-centered microwound, the sheath
flow injection mode was reversed to 10 ml min1 from the left
and 3 ml min1 from the right. Consequently, the focused flow of
trypsin–EDTA was re-directed towards the right. Micrographs
were taken before and after each wounding.
Pepsin–HCl epithelial layer wounding
To mimic microaspirations during episodes of gastric refluxes,
we developed a novel wounding agent based on two key
components of gastric refluxates, pepsin (Sigma-Aldrich) and
hydrochloric acid (HCl, Merck). To reduce diﬀusion-related
artefacts, we established an aqueous two-phase system (Fig. S3,
ESI†), based on the study reported by Frampton et al.,23 aimed at
cell co-culture patterning. 5% (w/w) high molecular weight dextran
(DEX 500 kDa, Pharmacosmos, Denmark) and 2.5% (w/w) low
molecular weight polyethylene glycol (PEG 35 kDa, Fluka) were
added to serum-free cell culture medium. Polymers were then
completely dissolved overnight using a rotator (Intelli-Mixer RM-2,
ELMI Ltd, Latvia), followed by centrifugation at 1000g for 15 min to
accelerate phase separation. Once the phases were fully separated,
both the PEG-rich upper and the DEX-rich lower phase appeared
clear with a sharp separation line at their interface. The lower phase
was then isolated and subsequently used as sheath flow. The upper
phase, in contrast, was acidified with HCl to pH 4. Then, pepsin was
added to reach a final concentration of 2.5 mg ml1. Acidification
processes were monitored using a pH-meter (SevenEasy, Mettler
Toledo). If needed, the pHwas readjusted after pepsin dissolution by
fine titration using diluted HCl and sodium hydroxide (NaOH,
Sigma). Prior to their use, both solutions, the DEX-rich lower phase
and the acidified and pepsin-supplemented PEG-rich upper phase,
were then filtered through 0.2 mm pored polyethersulfon syringe
filters (VWR) for sterilization.
Similar to the time to create the microwound analysis, the
microfluidic platform was mounted on the stage-top incubator
of the Zeiss LSM710. The acidified and pepsin-supplemented
wounding agent was then perfused at a 1 : 15 ratio with respect
to the pH-neutral DEX-phase. Micrographs of succeeding channel
segments along the entire microchannel were taken every other
minute to monitor the wound formation.
Results and discussion
Lung epithelial cells (A549) were cultured to confluence in a
microfluidic environment prior to being wounded. These cells
form a functional monolayer of type II alveolar epithelial cells
in such a perfused environment, as previously demonstrated by
immunostaining and transmission electron micrographs.19
Type II alveolar epithelial cells have self-renewal capacity and
were shown to be mainly responsible for epithelial regeneration
upon alveolar injury. Such systems have therefore been used to
investigate alveolar wound healing in vitro.28,29 While the cells
were cultured at a low flow rate of 0.1 ml min1 during the
growth phase, the flow conditions during the wounding phase
took place at an elevated flow rate of 15 ml min1, which
corresponds to a Reynolds number of 1.5 and to a shear stress
of about 1.5 dyne per cm2. This level of shear stress is well
within the physiologic range of 0.5–3 dyne per cm2 reported
during normal breathing.30 Although this shear stress is rather
small, it should be emphasized that mechanical stretch and shear
stress are considered to be crucial factors in the development of
epithelial microwounds in the lung.31–34 Particularly, during
acute exacerbations, the mechanical load on the epithelial cells
may increase disproportionately. A causal link between acute
exacerbations in IPF and occult microaspirations has recently
been postulated.35
To explore the versatility and the potential associated with this
wounding system, the alveolar epithelial cells were exposed to
various wounding patterns. The experimental procedure was
revealed to be very robust and reproducible. This high reproducibility
is attributed to the laminar flow conditions present in the
microfluidic system.
Trypsin–EDTA-induced injury: control of the wound width
It is the objective of this study to create microinjuries of smallest
possible dimensions, as they appear in vivo at the cellular level
within the alveolar sacs. Hydrodynamic focusing was used to
selectively expose a confluent layer of alveolar epithelial cells to
a series of diﬀerent flow conditions. Trypsin–EDTA was used as
the cell dissociation agent. Thereby, EDTA effectively chelates
divalent Mg2+ and Ca2+-ions from calcium-dependent cell adhesion
molecules (cadherins) and integrins. Similarly, trypsin prot-
eolytically cleaves cell anchoring and adhesion molecules, such
as integrins and cadherins. Consequently, cells exposed to the
focused flow of trypsin–EDTA were dissociated from the intact
cell layer and released from the substrate. Fig. 2 illustrates the
resulting microwounds in the alveolar epithelium obtained for the
five flow conditions examined. Wound widths were measured and
are summarized in Fig. 3. The standard deviations among all flow
conditions were found to be 10–16 mm, which correlates with the
size of a single A549 cell36 and is an excellent indicator of the
robustness and reproducibility of the technique. For the formation
of the smallest microwounds (flow ratio 1 : 30), trypsin–EDTA was
injected at 0.5 ml min1, while complete culture medium was
perfused at 7.25 ml min1 in the lateral inlets, resulting in a cell-
free area of only 42 mm in width. The size of the microwounds
corresponded very well with the area exposed to trypsin–EDTA,
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as shown in Fig. 2. The theoretical values of the central flow
widths were obtained by simulating the focused flow using
COMSOL Multiphysics. The results confirm both the accuracy
and the predictability of the experimental procedure.
The smallest microwounds presented here are 42 mm in
width. This correlates with an exposure pattern that only aﬀects
three to four neighbouring A549 cells.36 While wounding, marginal
flow fluctuations were observed. These fluctuations are most likely
due to technical limitations attributed to the syringe pumps and
the deformability of the plastic syringes used for injection. This
observation explains the slight diﬀerences between the theoretically
and experimentally determined wound widths. Furthermore,
due to this technical limitation, the formation of microwounds
with even smaller dimensions could not be accomplished.
Hypothetically, microwounds with dimensions of single cells
can be achieved by the use of either higher injection rates or
modified channel geometry (Fig. S1, ESI†). For this study,
however, the overall flow rate was fixed at 15 ml min1 and only
the central-to-sheath flow ratio was altered. Therefore, uniform
culture conditions were guaranteed among all flow conditions
examined.
Trypsin–ETDA-induced injury: time required for wound
creation
Hydrodynamic flow focusing enables targeted and selective cell
exposure to various wounding agents or particles. During
trypsin–EDTA wounding, cells exposed to the dissociation
agents gradually detach from both the neighbouring cells and
the underlying substrate. Consequently, affected cells undergo
apparent morphologic changes. In the first phase, tight cell–cell
contacts get disrupted and the cells start to round up. Following
this monolayer disruption, individual cells are progressively
detached and ultimately separated from the substrate. In micro-
fluidic wounding, dissociated cells are continuously washed
away by the fluid streams, resulting in straight and regular
microwounds (Video S1, ESI†). Interestingly, the time needed
for the formation of these microwounds strongly differed in the
function of the flow ratios (Fig. 4b). The smaller the wound
width, the longer it took to create an injury across the whole
channel length. To quantify the wound formation over time,
time-lapse microscopy of consecutive channel segments was
Fig. 2 Representative micrographs of hydrodynamic flow focusing in a 750 mmwide microchannel. Top line: pseudo-colored sodium fluorescein bound
by D-PBS; Bottom line: confluent A549 cells exposed to 0.5% trypsin–EDTA sheathed by complete culture medium under the respective flow conditions.
A series of five different flow conditions were investigated, while the overall flow rate was set at 15 ml min1: (a) ratio central-to-sheath flow 1 : 3 (blue);
(b) 1 : 5 (dark green); (c) 1 : 7.5 (light green); (d) 1 : 15 (orange); and (e) 1 : 30 (red). Scale bar: 200 mm.
Fig. 3 Resulting wound widths after hydrodynamic focusing of 0.5%
trypsin–ETDA on a confluent layer of A549 cells, cultured in a 750 mm-
wide microchannel. Data represent means  SD of 4 independent experi-
ments. A series of five different flow conditions were tested. Theoretical
wound widths were determined by COMSOL Multiphysics simulations.
Theoretical wound widths are displayed as dashed lines with the ratio
central-to-sheath flow of 1 : 3 (blue); 1 : 5 (dark green); 1 : 7.5 (light green);
1 : 15 (orange) and 1 : 30 (red).
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performed during wounding. The wound formation started at
the junction of the three inlet channels with the main channel.
From there on, the microwound gradually evolved across the
channel. Typically, wider wounds could be generated in only a
few minutes, while it took significantly more time to generate
smaller wounds. This observation reflects the diffusion phenomena
within the system. As previously mentioned, the focused flow of
trypsin–EDTA efficiently detaches cells from the substrate.
Meanwhile, unexposed cells are protected by the sheath flow
consisting of complete culture medium. There is, however, no
physical barrier between the cell dissociation agents and the
sheath flow. Consequently, diffusive transport occurs within the
system. The concentration of dissociation agents is therefore
gradually decreasing along the channel length. Lowest concen-
trations of cell dissociation agents are expected at the very end of
the channel. Further, the dissociative activity of trypsin–EDTA is
decreased not only due to the diffusion of trypsin–EDTA into the
sheathing cell culture medium, but also due to the diffusion
of inhibiting molecules from the sheath flow in the opposite
direction (e.g. Mg2+, Ca2+-ions and trypsin inhibitors). This
bi-directional diffusion leads to pronounced gradients in dissociative
activity along the channel length. Having a fixed overall flow rate of
15 ml min1 for all experiments, the residence time (tres) and
consequently diffusion lengths (LD) are identical among all flow
conditions examined [LD = (D tres)1/2, with the diffusion coefficient
D being constant]. Hence, smaller wounds are proportionally more
affected by diffusion phenomena than larger wounds, resulting in
longer latency for wound formation.
Trypsin–ETDA-induced injury: control of the wound position
To modify the positioning of the microwounds within the micro-
channel, complete culture medium was injected at unequal flow
rates in the lateral inlets. After convergence at the channel openings,
the unequal velocity profiles equilibrated quickly and generated a
fully developed parabolic flow profile within tens of micrometers.
Thus, the flow of trypsin–EDTA was directed towards the side of the
microchannel with the lower sheath flow injection rate. After the
formation of the first de-centered microwound, the flow ratio
between both sheath flows was reversed, so that the flow of
trypsin–EDTA was re-directed towards the opposing side of the
microchannel (Fig. 5). A second microwound was formed in the
epithelial layer in parallel to the pre-existing one. Since the ratio
between wounding and sheath flow was unaffected by this
adjustment, both microwounds are of identical widths.
In addition to the tailored woundwidth, we further demonstrate
the predictability and the precision in the wound positioning. In
combination with a highly confined trypsin–EDTA exposure,
multiple and parallel microwounds within a single epithelial
cell layer were achieved (Fig. 5 or Fig. S1, ESI†).
Pepsin–HCl-induced injury: use of physiologically relevant
wounding agents
To assess the eﬀect of gastric refluxates on the alveolar epithelium,
A549 cells were exposed to a focused flow of acidified pepsin-
supplemented serum-free culture medium. In the first set of
experiments, the wound creation stopped shortly after the flow
convergence at the channel openings (Fig. S2, ESI†). This observa-
tion can easily be explained by the rapid diﬀusion of H+-ions. In
contrast to the aforementioned experiments, the wounding agent
features a significant lower pH than the sheath flow (pH 4 vs.
pH 7.4). In other words, the concentration of H+-ions in the
wounding agent is three orders of magnitude higher than in the
sheath flow. Consequently, after convergence at the channel
entrance, H+-ions diﬀuse from the central wounding to the lateral
sheath flows. Due to the high diﬀusion coeﬃcient of protons
(Dproton E 2  109 m2 s1 vs. Dtrypsin E 2.2  1011 m2 s1),
diﬀusion phenomena are significantly more pronounced in
pepsin wounding than in trypsin–EDTA wounding. To overcome
this limitation, an aqueous two-phase system was developed
with the PEG-rich phase containing the key components of gastric
refluxates, HCl and pepsin. Prior to the pepsin dissolution, the
wounding phase was pre-acidified to prevent enzyme inactivation at
neutral pH-levels. Pepsin was then dissolved to a final concentration
of 2.5 mg ml1, which reflects the highest pepsin concentration
Fig. 4 Wound formation over time. Starting from the channel opening, microwounds gradually evolved across the entire channel length, as monitored
by time-lapse microscopy. Representative micrographs (a) are shown for a large wound (top line: ratio central-to-sheath flow 1 : 3) and a small wound
(bottom line: 1 : 30). Scale bar: 200 mm. Gradually evolving wound front (b) is shown for a series of decreasing wound widths: 243.4 mmwound (flow ratio
1 : 3; blue K); 156.9 mm wound (1 : 5; dark green ’); 109.2 mm (1 : 7.5; light green m); 62.0 mm (1 : 15; orangeE); and 41.7 mm (1 : 30; red .).
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found in the bronchoalveolar lavage (BAL) fluid of children
with GERD.37 This relatively high value is based on the following
two assumptions: (a) gastric refluxates are gradually diluted by
mucus and surfactants along the respiratory tract and (b) measure-
ments based on BAL fluids rather reflect the mean concentration
levels of the lavaged lung area than local peak values and are likely to
underestimate the effective concentrations due to severe dilution by
the lavage fluid. It is therefore plausible to assume highest peak
concentrations in individual alveoli right after reflux events. In some
cases, marginal pH-changes after dissolution of pepsin in pre-
acidified medium were observed. Fine titrations were therefore
needed for readjusting the ion-concentration to pH 4, which
correlates with the threshold value for acidic microaspirations.11
According to the study of Sweet and colleagues,9 a significant
portion (15%) of reflux events in GERD-positive IPF patients is
acidic, irrespective of pre-existing anti-reflux therapy. The mod-
ified wounding phase is revealed to remain phase-separated
from the sheath flow, which can easily be seen by the clear
separation line in Fig. 6 or Fig. S3 (ESI†). This phase-separation
is reported along the entire microchannel length. Control
experiments with fluorescent tracers, however, revealed that
the diffusion between the two-phases was significantly reduced,
but not fully prevented by the system (Fig. S4, ESI†). According
to Albertsson38 the exact mechanism at the interface is not well
understood and is affected by surface tension properties as well
as the densities of the two polymers. Nevertheless, the imple-
mentation of an aqueous two-phase system allowed for the
formation of pepsin–HCl based microwounds (Fig. 6).
Exposure to the acidified and pepsin-supplemented wounding
agent resulted in pronounced epithelial cell retraction and mono-
layer disruption at the site of exposure. Fig. S5 (ESI†) shows that
per se, neither the use of acidic medium nor the addition of pepsin
caused similar cell damage. Only in combination with a moderate
pH-level, pepsin was revealed to proteolytically cleave cell–cell
junctions, leading to the observed cell retraction and monolayer
disruption. Interestingly, time-lapse microscopy revealed that
the wound formation process underlying pepsin–HCl wounding
fundamentally differs from the aforementioned trypsin–ETDA
wounding. Whereas trypsin–ETDA exposure induces cleavage of
cell anchoring and cell adhesion molecules resulting in cellular
release from the substrate (Video S1, ESI†), little to no cell
detachment was observed during pepsin–HCl wounding (Video
S2, ESI†). This observation is in line with Paradise et al.’s
findings of integrin avb3 upregulation upon cellular exposure
to acidic pH.39 Cells exposed to pepsin–HCl tend to actively
migrate from the center to the periphery. This hypothesis is
further strengthened by the numerous cell protrusions observed
at the wound-edging cell border (Fig. 7). Furthermore, affected
cells featured slightly condensed cell nuclei. These morphologic
changes are indicative of DNA fragmentation during apoptosis.
These observations suggest that themicrowoundsmay rather be due
to the cellular reaction upon HCl-exposure than the consequence of
Fig. 5 Parallel microwounds in a 750 mm-wide microchannel. Schematic
drawing (a) and micrographs (b) of parallel wounding using a focused flow of
0.5% trypsin–EDTA. Precise control over the injection rates allows for targeted
localization of the focused wounding agents within the microchannel. Uneven
injection ratios between the two lateral sheath flows were used to de-centralize
the focused flow of trypsin–EDTA (green). After formation of the first
de-centered 100 mm-wound, the ratio between the lateral sheath flows was
reversed, which re-directed the wounding agent towards the opposing
channel side (blue), resulting in two uniform and parallel microwounds (c)
within a confluent layer of A549 cells. Scale bar: 100 mm.
Fig. 6 Time-lapse micrographs during pepsin–HCl-induced wounding of A549 cells cultured in a 750 mm-wide microchannel. A confluent layer of
A549 cells (a) was exposed to a focused flow of 2.5 mg ml1 pepsin in pre-acidified serum-free cell culture medium (pH 4). During wounding selective
disruption of the monolayer integrity was observed after a short time (b). After long-term exposure a continuous microwound with sharp and distinct
wound edges was achieved (c). Scale bar: 200 mm.
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proteolytic cleavage by pepsin (Fig. S5, ESI†). Further investiga-
tions are however needed to confirm these observations.
Relevance of proposed wounding model
Idiopathic pulmonary fibrosis is a complex and multi-factorial
disease. Formerly, anti-inflammatory therapies have been suggested,
but were revealed to be non-eﬀective in IPF. Consequently, to date,
therapeutic options remain limited, turning lung transplantation
into the last hope for cure in IPF patients. Following these early
findings, a new pathomechanism has been suggested. Accordingly,
pulmonary fibrosis is the consequence of unregulated wound repair
in the alveolus, which may evolve even in the absence of inflamma-
tion.40 Due to its ultrathin epithelium, its large surface area and its
exposed site, the human lung is indeed prone to injury. It was
therefore the aim of this study to reproduce alveolar wounding by
mimicking a hypothetical trigger of IPF, gastric microaspirations.
Thereby, we achieved wounds of in vivo-relevant dimensions
(o200 mm) and with in vivo-relevant wounding substances (HCl–
pepsin). The chosen concentrations of HCl–pepsin are based on the
current literature, butmay deviate from concentrations found in vivo.
The system was developed to recapitulate alveolar wounding in a
reproducible manner and is the first step in mimicking the complex
and multi-stage pathomechanism underlying IPF. The present
system reproduces microaspiration-induced alveolar wounding in a
new and unprecedented way and enables wound healing analysis
under precisely controlled conditions. We demonstrated HCl–pepsin
to synergistically damage alveolar epithelial cells, a finding that
directly supports the causal relation between GERD and IPF.
Furthermore, HCl–pepsin exposure better portrays the histo-
pathologic finding of apoptotic epithelial cells, as seen in IPF.41
Conclusions
Wounding assays have become a valuable and widespread tool
for the investigation of cell migration and wound healing.
Current wounding systems are often limited in reproducibility
and completely fail in modeling wounds with dimensions
relevant to the 200 mm wide human alveolus. The formation
of such microwounds is, however, of crucial importance for the
investigation of chronic lung diseases, such as idiopathic
pulmonary fibrosis. It was therefore the objective of this study
to create microinjuries of the smallest dimensions with the
highest clinical relevance. Thus, possibilities attributed to the
recently established microfluidic wounding were explored. The
technique was revealed to be robust and highly reproducible.
Microwounds of unprecedented dimensions were created and
precisely positioned in a microchannel. Further, a multiple of
these microinjuries were inflicted in a single epithelial cell
layer. Together, it can be concluded that microfluidic wounding
allows for tailor-made wounding patterns with unmatched
predictability over both the wound width and the wound
positioning. With the aid of an aqueous two-phase system, we
further demonstrated the versatility of the wounding procedure
by using the physiologically more relevant pepsin–HCl wounding
agent. Thereby, evidence is provided that episodes of mild acidic
exposure disrupt the epithelial barrier integrity, a key event in the
development of IPF. This simple wounding lung alveolar model
may further help to investigate the complex multi-factorial patho-
genesis of IPF.
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